Table 4.
Risk factors associated with respiratory syncytial virus (RSV) severity (length of hospital stay ≥ 11 days, intensive care unit admission, in-hospital death, or readmission to hospital within 30 days) in Valladolid, 2010–2022
| Variable | Adjusted OR | (95% CI) |
|---|---|---|
| Sex, male vs. female | 0.94 | (0.67, 1.31) |
| Resident in care institutions | 1.68 | (1.09, 2.61)* |
| Smoker (current) | 0.84 | (0.36, 1.95) |
| Smoker (previous) | 0.77 | (0.39, 1.55) |
| Immunocompromising condition | 1.01 | (0.72, 1.41) |
| Chronic lung disease | 1.00 | (0.78, 1.46) |
| Cardiovascular or cerebrovascular disease | 1.18 | (0.76, 1.84) |
| Kidney disease | 1.16 | (0.75, 1.77) |
| Liver disease | 1.27 | (0.70, 2.28) |
| Endocrine or metabolic disorder | 1.08 | (0.73, 1.52) |
| Neurologic condition | 1.23 | (0.85, 1.76) |
| Coinfection | 1.91 | (1.36,2.69)* |
OR odds ratio, 95% CI 95% confidence interval
*Statistically significant